BSF Enterprise (OTCQB: BSFAF)(LSE: BSFA)

BSF Enterprise PLC (BSF) is focused on unlocking the next generation of biotechnological solutions – using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes, as part of a radical transformation to deliver sustainable solutions across a variety of sectors. It owns 100% of 3D Bio-Tissues (3DBT), a tissue engineering with patent-protected IP that is already producing human corneas to help restore vision to millions of people. Building on this success, it aims to produce the UK’s first high quality lab-grown meat from its laboratory in Newcastle the next 12 months, transforming the meat-production industry towards an ethical and sustainable practice. BSF aims to deliver growth to shareholders through the continued commercialisation of 3DBT’s IP, which has multiple applications, as well as acquiring complementary businesses. It aims to acquire a suite of technologies that underpins the development of tissue templating for corneas, meat and leather, and license out the IP to manufacturers, wholesalers and distributors to help manufacture the products at scale. For further enquiries, please visit www.bsfenterprise.com

Interview with Geoff Baker, Executive Director

Investor Relations Contact:
Skyline Corporate Communications Group, LLC
Scott Powell, President
One Rockefeller Plaza, 11th Floor
New York, NY 10020
Office: (646) 893-5835
Email: info@skylineccg.com

The preceding/following post/interview was written and/or published as a collaboration between The Wall Street Analyzer’s in-house sponsored content team and Skyline Corporate Communications Group, LLC, a financial media partner of The Wall Street Analyzer. This article/video/podcast is a paid sponsorship by investor relations agency Skyline Corporate Communications Group, LLC, which is paid by BSF Enterprises (OTCQB: BSFAF)(LSE: BSFA)  for providing investor relations and corporate communications services relating to the Company’s securities. Please see Skyline’s 17(b) Disclaimer and Disclosure Statement here:https://skylineccg.com/disclosures/.  

Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. The content that follows is for informational purposes only and not intended to be investing advice.

About The Wall Street Analyzer 1500 Articles
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.